Vaksin COVID-19 Novavax
| Data klinikal | |
|---|---|
| Nama lain | NVX-CoV2373 |
| Kaedah pemberian | Intraotot |
| Pengecam | |
| DrugBank | |
Vaksin COVID-19 Novavax, bernama kod NVX-CoV2373, ialah calon vaksin COVID-19 yang dibangunkan oleh Novavax dan Coalition for Epidemic Preparedness Innovations (CEPI). Vaksin itu harus diberikan sebanyak dua dos[1] dan disimpan pada suhu 2 hingga 8 °C (36 hingga 46 °F).[2]
Rujukan
[sunting | sunting sumber]- ^ Wadman M, Jon C (28 January 2021). "Novavax vaccine delivers 89% efficacy against COVID-19 in UK—but is less potent in South Africa". Science. doi:10.1126/science.abg8101.
- ^ "New Covid vaccine shows 89% efficacy in UK trials". BBC News. 2021-01-28. Dicapai pada 2021-01-28.
.svg){kind=small}
Kategori:
- Infobox rencana dadah tanpa gambar struktur
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Dadah yang tidak mempunyai kod ATC
- Dadah tanpa status perundangan
- Articles containing unverified chemical infoboxes
- Infobox drug tracked parameters
- Vaksin COVID-19